ETC-1922159   Click here for help

GtoPdb Ligand ID: 11168

Synonyms: ETC-159 | ETC159 | ETC1922159
Compound class: Synthetic organic
Comment: ETC-1922159 (ETC-159) is an orally bioavailable, clinical stage porcupine inhibitor [1-3]. It is being developed for oncology potential.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 116.7
Molecular weight 391.14
XLogP 2.96
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(Cn1cnc2c1c(=O)n(C)c(=O)n2C)Nc1ccc(nn1)c1ccccc1
Isomeric SMILES O=C(Cn1cnc2c1c(=O)n(C)c(=O)n2C)Nc1ccc(nn1)c1ccccc1
InChI InChI=1S/C19H17N7O3/c1-24-17-16(18(28)25(2)19(24)29)26(11-20-17)10-15(27)21-14-9-8-13(22-23-14)12-6-4-3-5-7-12/h3-9,11H,10H2,1-2H3,(H,21,23,27)
InChI Key QTRXIFVSTWXRJJ-UHFFFAOYSA-N
Bioactivity Comments
ETC-1922159 is selective for human porcupine compared to the mouse and Xenopus homologues [3], and is active in a number of cancer xenograft models [4].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
porcupine O-acyltransferase Hs Inhibitor Inhibition 8.5 pIC50 - 3
pIC50 8.5 (IC50 2.9x10-9 M) [3]